Tilray Brands, Inc. Gain (Loss) on Sale of Financing Receivable
Tilray Brands, Inc. (TLRY) reported Gain (Loss) on Sale of Financing Receivable of -$9.70 million for the 12-month period ending 2020-05-31, per its 10-K filed 2021-07-28.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfNotesReceivable · last filed 2021-07-28
- Tilray Brands, Inc. gain (loss) on sale of financing receivable for fiscal 2020 was -$9.70M.
| Period end | Gain (Loss) on Sale of Financing Receivable 12 month |
|---|---|
| 2020-05-31 | -$9.70M 10-K · filed 2021-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |